This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Global Fluoroscopy And Mobile C-Arms Industry

NEW YORK, March 25, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Fluoroscopy and Mobile C-Arms Industry http://www.reportlinker.com/p098264/Global-Fluoroscopy-and-Mobile-C-Arms-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging

This report analyzes the worldwide markets for Fluoroscopy and Mobile C-Arms in Units and US$ Thousands by the following Product Segments: Fluoroscopy, and Mobile C-Arms (Full Size C-Arms, and Mini C-Arms). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

The report profiles 41 companies including many key and niche players such as GE Healthcare, Hologic, Inc., OrthoScan, Inc., Philips Healthcare, Shimadzu Corporation, Siemens Healthcare, Toshiba Medical Systems Corp., and Ziehm Imaging GmbH.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Full-Size C-Arm I-4Mini C-Arm I-4

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW II-1A Primer II-1Outlook II-1Recession Impact in Retrospect II-2Medical Equipment Industry Teeters under Eurozone Debt Crisis II-3Current & Future Analysis II-3Competitive Scenario II-4Growth Drivers and Limitations - A Glance II-4Growth Drivers in Detail II-5The 'Standard of Care' Nature of Fluoroscopy to Back theMarket II-5Increasing Number of Applications II-5Table 1: Global Cardio-Vascular X-ray Imaging EquipmentMarket by Segment (2010): Percentage Share Breakdown forCardiology, Vascular, and ElectroPhysiology (includescorresponding Graph/Chart) II-6Innovative Products to Drive the Market II-6Developing Geographies Prop Up Growth II-6Cost-Effectiveness and Versatility Factors Favor FluoroscopicProcedures II-7Growth in Minimally Invasive Procedures Spur Mobile C-ArmsMarket II-7Increasing Importance of Mini C-Arms in Sports and Clinics II-7Technological Evolutions Extend Opportunities for NewEntrants II-7Other Trends & Issues II-8Market Witnesses the Foray of Multimodality Systems II-8Conventional Systems Make Way for Digital Products II-8Newer Applications Drive Mobile C-Arms Market II-8Obese Patients Drive Manufacturers to Design New Equipment II-8Obesity Statistics-A Glance II-9ALARA Mandate - Fast Becoming Central to FluoroscopyPractices II-9Fluoroscopy Raises the Bar for Treatment in Orthopedics andPain Management II-10Flat Panel X-Ray Detectors to End Reign of Image IntensifierDigital Fluoroscopes? II-10Wireless and Retrofit Flat Panel Detectors Set to SwarmMarket II-11Impediments to Market Growth - An Insight II-11Higher Radiation Doses Play Spoilsport II-11

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs